Your browser doesn't support javascript.
loading
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
Goode, Ellen L; Block, Matthew S; Kalli, Kimberly R; Vierkant, Robert A; Chen, Wenqian; Fogarty, Zachary C; Gentry-Maharaj, Aleksandra; Toloczko, Aleksandra; Hein, Alexander; Bouligny, Aliecia L; Jensen, Allan; Osorio, Ana; Hartkopf, Andreas; Ryan, Andy; Chudecka-Glaz, Anita; Magliocco, Anthony M; Hartmann, Arndt; Jung, Audrey Y; Gao, Bo; Hernandez, Brenda Y; Fridley, Brooke L; McCauley, Bryan M; Kennedy, Catherine J; Wang, Chen; Karpinskyj, Chloe; de Sousa, Christiani B; Tiezzi, Daniel G; Wachter, David L; Herpel, Esther; Taran, Florin Andrei; Modugno, Francesmary; Nelson, Gregg; Lubinski, Jan; Menkiszak, Janusz; Alsop, Jennifer; Lester, Jenny; García-Donas, Jesús; Nation, Jill; Hung, Jillian; Palacios, José; Rothstein, Joseph H; Kelley, Joseph L; de Andrade, Jurandyr M; Robles-Díaz, Luis; Intermaggio, Maria P; Widschwendter, Martin; Beckmann, Matthias W; Ruebner, Matthias; Jimenez-Linan, Mercedes; Singh, Naveena.
Afiliación
  • Goode EL; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
  • Block MS; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA
  • Kalli KR; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA
  • Vierkant RA; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
  • Chen W; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada
  • Fogarty ZC; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
  • Gentry-Maharaj A; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, UK
  • Toloczko A; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
  • Hein A; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen-Nuremberg Comprehensive Cancer Center, Erlangen EMN, Germany
  • Bouligny AL; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
  • Jensen A; Department of Health Sciences, Spelman College, Atlanta, GA, USA
  • Osorio A; Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark
  • Hartkopf A; Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
  • Ryan A; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
  • Chudecka-Glaz A; Tübingen University Hospital, Department of Women's Health, Tübingen, Germany
  • Magliocco AM; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, UK
  • Hartmann A; Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland
  • Jung AY; Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL, USA
  • Gao B; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University
  • Hernandez BY; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Fridley BL; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia
  • McCauley BM; The Crown Princess Mary Cancer Centre, Westmead Hospital, The University of Sydney, Australia
  • Kennedy CJ; Cancer Center, University of Hawaii, Honolulu, HI, USA
  • Wang C; Department of Biostatistics and Bioinformatics, Division of Population Sciences, Moffitt Cancer Center, Tampa, FL, USA
  • Karpinskyj C; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
  • de Sousa CB; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia
  • Tiezzi DG; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia
  • Wachter DL; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
  • Herpel E; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, UK
  • Taran FA; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
  • Modugno F; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
  • Nelson G; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University
  • Lubinski J; Tissue Bank of the National Center for Tumor Diseases (NCT) Heidelberg, Germany and Institute of Pathology, University of Heidelberg, Heidelberg, Germany
  • Menkiszak J; Tübingen University Hospital, Department of Women's Health, Tübingen, Germany
  • Alsop J; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  • Lester J; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA
  • García-Donas J; Womens Cancer Research Program, Magee-Womens Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
  • Nation J; Department of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
  • Hung; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
  • Palacios J; Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland
  • Rothstein JH; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK
  • Kelley JL; Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • de Andrade JM; Medical Oncology Service, HM Hospitales ­ Centro Integral Oncológico HM Clara Campal, Madrid, Spain
  • Robles-Díaz L; Department of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
  • Intermaggio MP; Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia
  • Widschwendter M; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia
  • Beckmann MW; Pathology Department, Hospital Universitario Ramón y Cajal. IRYCIS. Universidad de Alcalá, Madrid, Spain. CIBERONC
  • Ruebner M; Department of Population Health Science and Policy, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • Jimenez-Linan M; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  • Singh N; Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
JAMA Oncol ; 3(12): e173290, 2017 12 01.
Article en En | MEDLINE | ID: mdl-29049607
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Linfocitos Infiltrantes de Tumor / Antígenos CD8 / Cistadenocarcinoma Seroso / Carcinoma Epitelial de Ovario Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Linfocitos Infiltrantes de Tumor / Antígenos CD8 / Cistadenocarcinoma Seroso / Carcinoma Epitelial de Ovario Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos